pharmaceutical investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo
pharmaceutical investing European Medicines Agency Validates Marketing Authorization Application for Trogarzo
pharmaceutical investing European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo
pharmaceutical investing Theratechnologies Announces Financial Results for the Second Quarter of 2018
pharmaceutical investing Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval
Apex Extends Trinity Zone 200 m with 3.55% REO over 116.0 m and 2.35% over 171.5 m in Western Step-out Drilling at Rift
Goldera Expands High-Grade E1 Gold Discovery with Two New Parallel Structures Ahead of Planned Q4 Drilling at Egan Gold Project
Oreterra CEO Letter to Shareholders Provides Forward Guidance on Trek South Drill Results in Advance of Assays